naltrexone has been researched along with fenfluramine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Sloman, L | 1 |
| Cohen, Y; Jacquot, C; Orosco, M; Robert, JJ; Rouch, C | 1 |
| Blundell, JE; Kirkham, TC | 1 |
| Shaw, WN | 1 |
| Campbell, M; Cueva, JE; Hallin, A; Schopler, E | 1 |
| Avanzini, P; Caccavari, R; Delsignore, R; Fertonani, G; Gerra, G; Lucchini, A; Rota-Graziosi, I; Zaimovic, A | 1 |
| Kaplan, LM | 1 |
3 review(s) available for naltrexone and fenfluramine
| Article | Year |
|---|---|
Use of medication in pervasive developmental disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Fenfluramine; Humans; Methylphenidate; Naltrexone; Psychotropic Drugs | 1991 |
Treatment of autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Behavior Therapy; Clomipramine; Clonidine; Fenfluramine; Humans; Naltrexone; Rehabilitation, Vocational; Selective Serotonin Reuptake Inhibitors; Speech Therapy | 1996 |
Pharmacologic therapies for obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Cyclobutanes; Ephedrine; Fenfluramine; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Weight Gain; Weight Loss | 2010 |
1 trial(s) available for naltrexone and fenfluramine
| Article | Year |
|---|---|
Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment.
Topics: Adult; Aggression; Antidepressive Agents, Second-Generation; Fenfluramine; Fluoxetine; Heroin Dependence; Hostility; Humans; Male; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Psychiatric Status Rating Scales; Treatment Outcome | 1995 |
5 other study(ies) available for naltrexone and fenfluramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Effects of dexfenfluramine and opioid peptides, alone or in combination, on food intake and brain serotonin turnover in rats.
Topics: Animals; beta-Endorphin; Brain; Drug Interactions; Dynorphins; Eating; Endorphins; Enkephalin, Leucine; Female; Fenfluramine; Naltrexone; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine.
Topics: Animals; Dextroamphetamine; Endorphins; Feeding Behavior; Fenfluramine; Male; Naloxone; Naltrexone; Rats; Reaction Time; Satiation | 1986 |
Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants.
Topics: Albuterol; Animals; Appetite Depressants; Cyclohexanes; Dextroamphetamine; Drug Tolerance; Eating; Endorphins; Female; Fenfluramine; Injections, Subcutaneous; Male; Naltrexone; Obesity; Piperidines; Rats; Rats, Zucker; Weight Gain | 1993 |